Almost half of these occur in Asia with almost one quarter of the global burden in China. The top three cancers in women are breast, lung, and cervical cancers. In men the top three cancers are lung, stomach, and liver cancers. Availability of large patient population, high quality medical facilities and the relatively low cost of running clinical trials have helped Asia emerge as a prime location for conducting Oncology trials. However, for most sponsors conducting oncology trials in Asia, navigating the maze of trial logistics, local regulatory requirements and cultural differences can present major challenges without the expertise of a regional CRO.
Key Topics:
- Cultural Requirements
- Patient Demographics
- Regulatory Requirements
- Site Selection
Watch Dr John Moller Chief Operating Officer Asia, Donna Fraser Associate Director Clinical Operations and Chin Wee Tan Clinical Operations Manager Singapore discuss strategies for managing Oncology clinical trials in Asia.
Watch the online presentation in a new browser window: